These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2880726)

  • 21. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
    Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the antiarrhythmic and the proarrhythmic effect of almokalant in anaesthetised rabbits.
    Farkas A; Leprán I; Papp JG
    Eur J Pharmacol; 1998 Apr; 346(2-3):245-53. PubMed ID: 9652366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiarrhythmic effects of selective beta 1- and beta 2- and nonselective beta-adrenoceptor blockade in normokalaemic and dietary-induced hypokalaemic rats.
    Winslow E; Walker G; Mason R
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):673-80. PubMed ID: 2481179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M; Ray A; Sen P
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effects of bupuranolol against canine ventricular arrhythmias induced by halothane-adrenaline or two-stage coronary ligation.
    Hashimoto K; Tsukada T; Matsuda H; Nakagawa Y; Imai S
    J Cardiovasc Pharmacol; 1979; 1(2):205-17. PubMed ID: 94390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
    Evans DB; Peschka MT; Lee RJ; Laffan RJ
    Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease.
    Swerdlow C; Peterson J; Liem LB; Blake K; Franz MR; Laddu A
    Am J Cardiol; 1987 Nov; 60(13):1055-60. PubMed ID: 2890290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
    Quon CY; Gorczynski RJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 30. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
    Reilly CS; Wood M; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective beta 1 and beta 2 adrenoceptor blockade on epinephrine-induced arrhythmias in halothane anaesthetized dogs.
    Hayashi Y; Sumikawa K; Kamibayashi T; Yamatodani A; Mammoto T; Kuro M; Yoshiya I
    Can J Anaesth; 1992 Oct; 39(8):873-6. PubMed ID: 1283841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
    Uprichard AG; Harron DW; Wilson R; Shanks RG
    Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preconditioning modulates susceptibility to ischemia-induced arrhythmias in the rat heart: the role of alpha-adrenergic stimulation and K(ATP) channels.
    Ravingerová T; Pancza D; Ziegelhoffer A; Styk J
    Physiol Res; 2002; 51(2):109-19. PubMed ID: 12108920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled beta-receptor blockade with esmolol and flestolol.
    Murthy VS; Frishman WH
    Pharmacotherapy; 1988; 8(3):168-82. PubMed ID: 2902602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs.
    Dimich I; Lingham R; Narang J; Sampson I; Shiang H
    Can J Anaesth; 1992 Jan; 39(1):83-6. PubMed ID: 1346371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of concordance between the antiarrhythmic and antifibrillatory actions of UM-424, a quaternary ammonium analogue of propranolol.
    Lynch JJ; Montgomery DG; Nelson SD; Huante DM; Lucchesi BR
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):414-24. PubMed ID: 2438504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.